2 recruiting, 1 active not recruiting, 1 completed, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Atypical Parkinson Disease: new trials by email Literature Review of Atypical Parkinson Disease trials Research Report on Atypical Parkinson Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin Therapy for Psychological Distress in Palliative Patients Psilocybin therapy - COPD (Chronic Obstructive Pulmonary Disease), ALS (Amyotrophic Lateral Sclerosis) | Phase 2 | Recruiting | University Medical Center Groningen | 108 | 2025-07-01 | 2026-05-08 |
| Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions. - Gait Disorders, Neurologic, Atypical Parkinson Disease | Recruiting | Karolinska Institutet | 30 | 2025-03-14 | 2026-10-22 | |
| In-Home Care for Patients With PSP and Related Disorders Home Visit Program, Usual Care/Online Survey - Progressive Supranuclear Palsy, Dementia With Lewy Bodies | Not applicable | Completed | Rush University Medical Center | 56 | 2018-05-30 | 2024-04-01 |
| Gait Analysis in Neurological Disease Anti-Parkinson medication, Deep Brain Stimulation - Parkinson's Disease, Parkinsonian Disorders | Active not recruiting | Beth Israel Deaconess Medical Center | 120 | 2016-03-01 | 2026-07-08 | |
| Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury Combination injection of EPO and G-CSF, Injection of normal saline - Neurological Diseases, Ischemic Stroke | Phase 1 / Phase 2 | Unknown | Yonsei University | 60 | 2011-07-05 | 2020-12-28 |
Parkinson Disease, Familial, Type 1 (5) · Corticobasal Degeneration (2) · Gait Disorders, Neurologic (2) · Multiple System Atrophy (2) · Supranuclear Palsy, Progressive (2) · Amyotrophic Lateral Sclerosis (1) · Cerebral Palsy (1) · Depression (1) · Depressive Disorder, Major (1) · Hemorrhagic Stroke (1) · Huntington Disease (1) · Ischemic Stroke (1) · Lewy Body Disease (1) · Multiple Sclerosis (1) · Parkinson Disease (1)
Nervous System Diseases (5) · Central Nervous System Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Brain Diseases (3) · Mental Disorders (3) · Neurodegenerative Diseases (3) · Neurologic Manifestations (3) · Signs and Symptoms (3) · Autonomic Nervous System Diseases (2) · Basal Ganglia Diseases (2) · Cranial Nerve Diseases (2) · Dementia (2) · Eye Diseases (2) · Movement Disorders (2) · Neurocognitive Disorders (2)
Amantadine (1) · Deep Brain Stimulation (1) · Granulocyte Colony-Stimulating Factor (1) · Pramipexole (1) · Tolcapone (1) · carbidopa, levodopa drug combination (1) · entacapone (1) · ropinirole (1)
Beth Israel Deaconess Medical Center (1) · Karolinska Institutet (1) · Rush University Medical Center (1) · University Medical Center Groningen (1) · Yonsei University (1)
United States (2) · Czechia (1) · Denmark (1) · Netherlands (1) · Portugal (1) · South Korea (1) · Sweden (1)
Franziska Albrecht, PhD (1) · Jori Fleisher, MD (1)
2023 (1)